To the full analysis
Scotts Miracle-Gro stock: growth
SMGScotts Miracle-Gro reported $3.29B in revenue for fiscal 2026, down 3.6% on the prior year, down 7.8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
0.7%
per year from 2007 to 2026, per share 1.3%
Earnings (Annual rate)
−0.5%
per year from 2007 to 2026, per share 0.1%
Free cash flow (Annual rate)
2%
per year from 2007 to 2026, per share 2.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | −7.8% | 1.5% | 0.7% |
| Revenue per share | −8.5% | 2.0% | 1.3% |
| Earnings | −27.3% | −10.6% | −0.5% |
| Earnings per share | −27.9% | −10.0% | 0.1% |
| Free cash flow | 11.1% | 4.5% | 2.0% |
| Free cash flow per share | 10.1% | 5.0% | 2.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $2.87B | $113.4M | $192.6M |
| 2008 | $2.98B | −$10.9M | $144.8M |
| 2009 | $2.98B | $153.3M | $189.2M |
| 2010 | $3.14B | $204.1M | $212.5M |
| 2011 | $2.84B | $167.9M | $49.4M |
| 2012 | $2.83B | $106.5M | $84M |
| 2013 | $2.82B | $161.1M | $281.9M |
| 2014 | $2.84B | $166.5M | $153.3M |
| 2015 | $3.02B | $159.8M | −$114.8M |
| 2016 | $2.84B | $320.3M | $179.1M |
| 2017 | $2.64B | $218.3M | $284.4M |
| 2018 | $2.66B | $63.7M | $274.3M |
| 2019 | $3.16B | $460.7M | $184.4M |
| 2020 | $4.13B | $387.4M | $495.3M |
| 2021 | $4.93B | $512.5M | $164.6M |
| 2022 | $3.92B | −$437.5M | −$242.5M |
| 2023 | $3.55B | −$380.1M | $438.2M |
| 2024 | $3.55B | −$34.9M | $583.5M |
| 2025 | $3.41B | $145.2M | $273.9M |
| 2026 | $3.29B | $103.9M | $278.4M |
Revenue by region
Where The Scotts Miracle-Gro Company generates its revenue.
- United States92%
- Outside the US8%
Figures as a table
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| United States | $2.38B | $2.85B | $3.77B | $4.51B | $3.55B | $3.21B | $3.25B | $3.13B | 91.8% |
| Outside the US | $287.9M | $304.1M | $358.2M | $418M | $369.5M | $341.8M | $304.9M | $278.6M | 8.2% |
| Total revenue | $2.66B | $3.16B | $4.13B | $4.93B | $3.92B | $3.55B | $3.55B | $3.41B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Sep 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 21 Oct 2026)
- Valuation signal Fairly valued since 11 Nov 2026, previously Undervalued
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.